CalabreseG, LicataG, GambardellaA, et al.Topical and conventional systemic treatments in atopic dermatitis: have they gone out of fashion?. Dermatol Pract Concept. 2022; 12(1):e2022155.
2.
RatchataswanT, BanzonTM, ThyssenJP, et al.Biologics for treatment of atopic dermatitis: current status and future prospect. J Allergy Clin Immunol Pract. 2021; 9(3):1053–1065.
3.
WuSE, ChenYH, ChungCH, et al.Atopic dermatitis as a risk factor for herpes zoster infection independent of treatment: a Nationwide Population-Based Cohort Study. Dermatitis. 2023; 34(3):241–249.
4.
EichenfieldLF, BieberT, BeckLA, et al.Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis. Am J Clin Dermatol. 2019; 20(3):443–456.
5.
WollenbergA, BlauveltA, Guttman-YasskyE, et al.Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2021; 184:437–449.
